Ganjiebingmei Tablet (甘桔冰梅片) in Treating Acute Pharyngitis with Wind-Heat Invading the Lung Syndrome: A Multicenter, Randomized, Double-blind Double-dummy Clinical Observation
|更新时间:2024-05-13
|
Ganjiebingmei Tablet (甘桔冰梅片) in Treating Acute Pharyngitis with Wind-Heat Invading the Lung Syndrome: A Multicenter, Randomized, Double-blind Double-dummy Clinical Observation
Journal of Traditional Chinese MedicineVol. 65, Issue 10, Pages: 1033-1037(2024)
ZHAO Dongming,WANG Guang'en,GAO Yuan,et al.Ganjiebingmei Tablet (甘桔冰梅片) in Treating Acute Pharyngitis with Wind-Heat Invading the Lung Syndrome: A Multicenter, Randomized, Double-blind Double-dummy Clinical Observation[J].Journal of Traditional Chinese Medicine,2024,65(10):1033-1037.
ZHAO Dongming,WANG Guang'en,GAO Yuan,et al.Ganjiebingmei Tablet (甘桔冰梅片) in Treating Acute Pharyngitis with Wind-Heat Invading the Lung Syndrome: A Multicenter, Randomized, Double-blind Double-dummy Clinical Observation[J].Journal of Traditional Chinese Medicine,2024,65(10):1033-1037.DOI: 10.13288/j.11-2166/r.2024.10.010.
Ganjiebingmei Tablet (甘桔冰梅片) in Treating Acute Pharyngitis with Wind-Heat Invading the Lung Syndrome: A Multicenter, Randomized, Double-blind Double-dummy Clinical Observation
(甘桔冰梅片, GBT) in treating acute pharyngitis with wind-heat invading the lung syndrome.
Methods
2
Using multi-center, rando-mized, double-blind, double-dummy, positive and parallel controlled clinical trial design, 144 acute pharyngitis patients with wind-heat invading the lung syndrome from October 8th, 2022 to March 31st, 2023 were collected and randomly assigned to the treatment group and the control group, with 72 cases in each group. The treatment group was treated by GBT (0.4 g eac
h time, 4 times a day) combined with
Ganjie Qingyan Granules
(甘桔清咽颗粒, GQG) placebo (10 g each time, 3 times a day), while the control group was treated by GQG (10 g each time, 3 times a day) combined with GBT placebo (0.4 g each time, 4 times a day), both for 5 days. The clinical efficacy of the two groups was observed, and the disappearance rate of pharyngalgia and the efficacy regarding TCM syndromes were compared between groups after treatment. The visual analog scale (VAS) score before and after treatment was assessed, and the safety was evaluated.
Results
2
The disappearance rate of pharyngalgia in the treatment group was 98.61%(71/72), significantly higher than 80.56%(58/72) in the control group (
P
<0.01). The VAS scores in both groups significantly decreased after treatment (
P
<0.05), and lower score was found in the treatment group than the control group (
P
<0.05). The total effective rate regarding TCM syndromes was 100% in both groups, but the curative rate was significantly higher in the treatment group(73.61%, 53/72) than the control group (62.50%, 45/72,
P
<0.05). There were no obvious adverse reactions in the both groups.
Conclusion
2
GBT is effective and safe in treating acute pharyngitis with wind-heat affecting the lung syndrome.
Clinical Effectiveness and Safety of Bairui Granules (百蕊颗粒) in Treating Patients with Acute Pharyngitis with Wind-Heat Syndrome: A Multi-Center, Double-Blind, Double-Simulation, Randomized Controlled Trial
Methodological Issues in the Design,Evaluation,and Reporting of Randomized Controlled Trials with "Pattern Dominating Disease"
Effect of Electroacupuncture on Metabolism-Inflammation Network in Patients with Simple Obesity:A Randomized Controlled Trial
Acupuncture Treatment for Severe Bell's Palsy and Its Impact on Serum GDNF and NGF:A Randomized Controlled Trial
Effect of Heat-sensitive Moxibustion on Quality of Life and Immune Function in Non-Small Cell Lung Cancer Patients with Qi Deficiency and Phlegm Stasis Syndrome Undergoing Chemotherapy:A Randomized Controlled Trial
Related Author
LIU Siming
ZHOU Hui
LI Qiang
ZHOU Min
WU Qixiang
YANG Shanjun
WANG Jun
YUAN Jingjing
Related Institution
Dongzhimen Hospital,Beijing University of Chinese Medicine